Register entry
CORIUM LLC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 22
- Countries
- 0
Exclusivity
Patents and exclusivities
22| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 12161767 | ADLARITYdonepezil hydrochloride | substance, product | Dec 2036 |
| 12168075 | ADLARITYdonepezil hydrochloride | use | Dec 2036 |
| 11679086 | ADLARITYdonepezil hydrochloride | use | May 2037 |
| 10016372 | ADLARITYdonepezil hydrochloride | use | Jul 2037 |
| 10300025 | ADLARITYdonepezil hydrochloride | product | Jul 2037 |
| 10307379 | ADLARITYdonepezil hydrochloride | product | Jul 2037 |
| 11103463 | ADLARITYdonepezil hydrochloride | use | Jul 2037 |
| 9993466 | ADLARITYdonepezil hydrochloride | product | Jul 2037 |
| 11648214 | ADLARITYdonepezil hydrochloride | product | Sept 2037 |
| 10835499 | ADLARITYdonepezil hydrochloride | product | May 2038 |
| 10966936 | ADLARITYdonepezil hydrochloride | product | Aug 2038 |
Enquiry
Common questions
- Is CORIUM LLC FDA approved?
- CORIUM LLC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.